New notifiable conditions in South Australia
08 October 2021
A number of notifiable conditions have been added to the South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2012 (the Regulations). Additionally, for notifiable AEFI, the notifying groups have been expanded. The changes came into effect on 7th October 2021.
1. Notifiable Adverse Event Following Immunisation (AEFI)
- The following groups are now required to notify notifiable AEFI to SA Health:
- An AEFI is any untoward medical occurrence that follows immunisation. It does not necessarily have a causal relationship with the vaccine. A notifiable AEFI is an AEFI occurring after any vaccine that is not a very common or common AEFI.
- For further detail on what is considered a very common or common AEFI refer to the Australian Immunisation Handbook (https://bit.ly/3uvcWla) or Australian Technical Advisory Group on Immunisation (ATAGI) advice (https://bit.ly/3AYvM6J).
- Health practitioners will be exempt from notifying SA Health of a notifiable AEFI if they know or reasonably believe a report has already been made by another health practitioner who has a requirement to notify AEFI.
- Healthcare providers, as detailed above, must report notifiable AEFI to SA Health but, in addition may choose to also report these AEFI directly to the Therapeutic Goods Administration (TGA). AEFI reports received by SA Health are deidentified and sent to the TGA.
2. Respiratory syncytial virus (RSV)
- Doctors only need to notify cases where they suspect a person has died from RSV.
- Pathology services will need to notify all RSV infections.
3. Invasive group A streptococcal disease (iGAS)
- iGAS is defined by the isolation of GAS from a normally sterile site. Manifestations include bacteraemia/septicaemia (including maternal sepsis), streptococcal toxic shock syndrome, necrotising fasciitis, pneumonia/empyema and meningitis.
4. Candia auris
- Candida auris is a newly emerging, multi-resistant fungus that is of particular concern due to its high mortality rate and ability to spread within healthcare and residential aged care settings.
5. Lyssavirus infection (including rabies, Australian bat lyssavirus and other lyssavirus infections)
- This is replacing rabies and Australian bat lyssavirus infection in the Regulations.
6. West Nile virus infection (including Kunjin variant)
- This is replacing Kunjin virus infection in the Regulations.
Doctors and healthcare providers authorised to vaccinate are advised to:
- Notify all AEFI (except for very common or common AEFI) to SA Health.
- Use the online Vaccine Reaction Report Form available at: https://extapps2.sahealth.sa.gov.au/SAVSS/ OR
- Telephone the Immunisation Section, Communicable Disease Control Branch (CDCB) between 8.30am – 5.00pm work days on 1300 232 272.
Doctors are advised to:
- Urgently notify suspected and confirmed cases of iGAS, Candida auris, West Nile virus infection (including Kunjin variant) and lyssavirus infection (including rabies, Australian bat lyssavirus and other lyssavirus infections) by phone to CDCB on 1300 232 272 (24 hours/7 days).
- Notify CDCB of all cases where they suspect a person has died from RSV by completing an electronic Report of Notifiable Condition or Related Death form (available at https://extapps2.sahealth.sa.gov.au/CDCB-Notify/). Alternatively fax a Report of Notifiable Condition or Related Death form to CDCB using the fax number (08) 7425 6696.
For all enquires please contact the CDCB on 1300 232 272 (24 hours/7 days)
Dr Louise Flood – Director, Communicable Disease Control Branch